Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1967 1
1968 2
1969 1
1972 4
1973 4
1974 2
1975 3
1976 7
1977 4
1978 8
1979 3
1980 7
1981 6
1982 6
1983 2
1984 2
1985 5
1986 4
1987 8
1988 5
1989 7
1990 3
1991 7
1992 11
1993 11
1994 9
1995 6
1996 9
1997 8
1998 5
1999 2
2000 2
2001 4
2002 2
2003 2
2004 3
2005 1
2006 1
2007 1
2012 1
2015 1
2016 3
2017 2
2018 5
2019 5
2020 5
2021 9
2022 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for samsonov m[au]
Your search for Samonov M[au] retrieved no results
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Smolen JS, Feist E, Fatenejad S, Grishin SA, Korneva EV, Nasonov EL, Samsonov MY, Fleischmann RM; CREDO2 Group. Smolen JS, et al. Among authors: samsonov my. N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302. N Engl J Med. 2022. PMID: 36001712 Clinical Trial.
Coronavirus Infection 2019 (COVID-19) and Autoimmunity.
Nasonov EL, Samsonov MY, Lila AM. Nasonov EL, et al. Among authors: samsonov my. Her Russ Acad Sci. 2022;92(4):398-403. doi: 10.1134/S1019331622040062. Epub 2022 Sep 6. Her Russ Acad Sci. 2022. PMID: 36091857 Free PMC article.
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study.
Feist E, Fatenejad S, Grishin S, Korneva E, Luggen ME, Nasonov E, Samsonov M, Smolen JS, Fleischmann RM. Feist E, et al. Among authors: samsonov m. Ann Rheum Dis. 2022 Dec;81(12):1661-1668. doi: 10.1136/ard-2022-222630. Epub 2022 Sep 15. Ann Rheum Dis. 2022. PMID: 36109142 Free PMC article. Clinical Trial.
Anaphylatoxins in dilated cardiomyopathy.
Samsonov M, Nassonov E, Masenko V, Naumov V, Mareev V, Belenkov Y. Samsonov M, et al. J Intern Med. 1993 Aug;234(2):139-42. doi: 10.1111/j.1365-2796.1993.tb00722.x. J Intern Med. 1993. PMID: 8340735
219 results